Table of Contents
Cover image

Skeletal tumor burden on baseline fluoride PET/CT has been shown to be a predictive biomarker of survival and skeleton-related events in patients treated with 223Ra. See page 1177.
Skeletal tumor burden on baseline fluoride PET/CT has been shown to be a predictive biomarker of survival and skeleton-related events in patients treated with 223Ra. See page 1177.